These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32799052)

  • 1. A cheminformatic study on chemical space characterization and diversity analysis of 5-LOX inhibitors.
    Ahamed TKS; Muraleedharan K
    J Mol Graph Model; 2020 Nov; 100():107699. PubMed ID: 32799052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening.
    Cerchia C; Küfner L; Werz O; Lavecchia A
    Eur J Med Chem; 2024 Jan; 263():115932. PubMed ID: 37976708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
    Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase.
    Shameera Ahamed TK; Rajan VK; Sabira K; Muraleedharan K
    Comput Biol Chem; 2018 Dec; 77():154-166. PubMed ID: 30321850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.
    Sinha S; Doble M; Manju SL
    Bioorg Med Chem; 2019 Sep; 27(17):3745-3759. PubMed ID: 31331653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase.
    Schneider I; Bucar F
    Phytother Res; 2005 Feb; 19(2):81-102. PubMed ID: 15852496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP.
    Klegeris A; McGeer PL
    J Leukoc Biol; 2003 Mar; 73(3):369-78. PubMed ID: 12629151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase.
    Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Matzke M; Pleiss U; Keldenich J; Müller-Peddinghaus R
    Agents Actions; 1994 Nov; 43(1-2):64-8. PubMed ID: 7741044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Mechanistic insights into 5-lipoxygenase inhibition by active principles derived from essential oils of Curcuma species: Molecular docking, ADMET analysis and molecular dynamic simulation study.
    Gadnayak A; Dehury B; Nayak A; Jena S; Sahoo A; Panda PC; Ray A; Nayak S
    PLoS One; 2022; 17(7):e0271956. PubMed ID: 35867724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
    Muthuraman S; Sinha S; Vasavi CS; Waidha KM; Basu B; Munussami P; Balamurali MM; Doble M; Saravana Kumar R
    Bioorg Med Chem; 2019 Feb; 27(4):604-619. PubMed ID: 30638966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
    Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M
    Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
    El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM
    Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer modeling in predicting the bioactivity of human 5-lipoxygenase inhibitors.
    Zhang M; Xia Z; Yan A
    Mol Divers; 2017 Feb; 21(1):235-246. PubMed ID: 27904990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.
    Bruno F; Spaziano G; Liparulo A; Roviezzo F; Nabavi SM; Sureda A; Filosa R; D'Agostino B
    Eur J Med Chem; 2018 Jun; 153():65-72. PubMed ID: 29133059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.
    Gür ZT; Çalışkan B; Banoglu E
    Eur J Med Chem; 2018 Jun; 153():34-48. PubMed ID: 28784429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
    Celotti F; Durand T
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
    Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
    Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic modeling of human 5-lipoxygenase-inhibitor interactions helps to discover novel inhibitors.
    Wu Y; He C; Gao Y; He S; Liu Y; Lai L
    J Med Chem; 2012 Mar; 55(6):2597-605. PubMed ID: 22380511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.